The Cuban firm HeberBiotec S.A. signed in Hanoi an agreement with Duc Minh Medical J.S.C., from Vietnam's AMV Group to export next 2016 to the Asian country seven products worth 3.2 million USD.
Under the deal, Cuba will sell Vietnam the product Heberbiovac HB 10 mcg, of therapeutic action against Hepatitis B in newborn babies and children under 10.
Cuba will also export Heberbiovav HB 20 mcg (for adults), quimi-hip (a vaccine against the bacterium Haemophilus influenzae type b), Heberon Alpha R (recombinant human interferon alfa 2b), PEG-Heberon (pegylated Interferon), Heberitro (recombinant human erythropoietin alpha) y Hebervital (human G-CSF).
These products represent an increase of 30 percent against this year, Mai Thao, Sales Manager of HeberBiotec S.A., the marketing business for products and projects of the Center for Genetic Engeneering and Biotechnology (CIGB) of Cuba.
Before signing the agreement, Thao made emphasis on the seriousness of the annual plan drafted by the parties and the payment by the AMV Group.
He revealed that thus far this year products were sold worth 2.4 million USD, from 2.2 million expected, and in the 15 years of joint collaboration all plans have been fulfilled.
Cuban Ambassador to Vietnam, Herminio Lopez, said this pact is another step in strengthening the links in the biopharmaceutical and biotechnology fields and expressed hope for the links to multiply so as to have much more opportunities for mutual benefit. / PL.